Gba1 Mutant Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GBA1 mutations represent the most significant genetic risk factor for Parkinson's disease. GBA1 encodes glucocerebrosidase (GCase), a lysosomal enzyme whose deficiency leads to accumulation of glucocerebroside and impaired autophagy, creating a pro-neurodegenerative cellular environment. [1]
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [2]
The study of Gba1 Mutant Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [3]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mazzulli et al. Gaucher disease glucocerebrosidase and α-synuclein form a pathogenic complex (2011). 2011. ↩︎
Schapira & Gegg, Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease (2011). 2011. ↩︎
Bennett & Boya, The relationship between GBA deficiency and the pathogenesis of Parkinson's disease (2020). 2020. ↩︎